STOP-HSP.Net: a Registry for Hereditary Spastic Paraplegia as an Integration Tool for Future Therapeutic Strategies
IRCCS Fondazione Stella Maris
500 participants
Jan 24, 2024
OBSERVATIONAL
Conditions
Summary
Our goal is to create a solid and harmonious disease registry of patient affected by hereditary spastic paraplegia (HSP) that facilitates the collection and management of patients' data over time encouraging the research and the development of future clinical trials. In-depth clinical phenotyping will develop significant clinical outcome measures that can be used in clinical trials and will allow the phenotypic complexity of the disease to be captured with the use of validated clinical scales, biomarkers and so-called patient reported outcomes (PROs).
Eligibility
Inclusion Criteria2
- clinical diagnosis of pure or complex HSP/spastic ataxia, even in the absence of a known genetic diagnosis
- participants/parents/legal guardians will have to give informed consent for enrollment in the registry and privacy data management
Exclusion Criteria3
- subjects affected by secondary forms of HSP
- presenting comorbidities that affect the general clinical picture according to clinical judgment
- lack of informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06572046